BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200414
DTEND;VALUE=DATE:20200418
DTSTAMP:20260515T074935
CREATED:20191105T115338Z
LAST-MODIFIED:20200407T153017Z
UID:23236-1586822400-1587167999@www.pharmajournalist.com
SUMMARY:eyeforpharma Philadelphia Virtual
DESCRIPTION:“As we self-isolate\, we must be careful not to isolate our ideas and thoughts. Ironically\, it has never been more important for our industry to share\, collaborate and inspire. For that reason\, we have not cancelled the eyeforpharma Philadelphia meeting\, but we’re moving it online. It is also now entirely free of charge to attend. I’m humbled that the speakers and supporters that were due to present are moving online with us\, and share with us a desire to ‘do what we can’ to make sure that we carry on communicating. I believe the event will be stronger than ever\, and more influential – at just the right time.” \n \nPaul Simms\, Chairman\, eyeforpharma \nWhy eyeforpharma Philadelphia Virtual is essential viewing: \n\nIt’s free for all to join: In such a difficult time\, we want to unify the industry and we’ve taken the decision to allow anyone to sign up to listen live\, ask questions and participate. If you work for a pharma or biotech\, you’ll also get access to a full meeting service so you can set up bespoke 1-1 meetings with fellow attendees.\n\n\nA speaker faculty even better than before: You’ll learn from 100+ speakers with 60+ free sessions – presentations\, panels\, fireside chats\, interactive workshops and Q&A\, You’ll also see hours of additional live and on-demand content\, including never-before-seen interviews with Kabir Nath\, President & CEO North America\, Otsuka\, Julie Gerberding\, EVP and Chief Patient Officer\, Communications\, Global Policy and Population Health\, Merck\, James Musick\, VP and Head of Digital Transformation\, Neurology\, UCB\, and many more.\n\n\nConnect with industry leaders around the world: Without the constraints of geography\, we’ll have thousands of industry leaders from across the globe coming together to network and collaborate.\n\n\nComplete virtual meetings platform: Send messages to connect 1-on-1 with your fellow attendees. Schedule meetings and use a virtual private meeting room to chat.\n\n\nFull virtual exhibition: Showcasing over 50+ exhibitors\, search for the latest services and technology solutions from your desk\, watch demo videos and the ability to share your virtual business card.\n\nRegister for FREE here: https://bit.ly/2UPFCVZ Join the conversation and become healthcare’s solution.
URL:https://www.pharmajournalist.com/event/eyeforpharma-philadelphia-virtual/
LOCATION:Online\, PA
ORGANIZER;CN="eyeforpharma":MAILTO:ksharp@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200415
DTEND;VALUE=DATE:20200418
DTSTAMP:20260515T074935
CREATED:20191215T132554Z
LAST-MODIFIED:20191215T132652Z
UID:23361-1586908800-1587167999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit 2020
DESCRIPTION:More and more pharma and biotech companies are investing in research focused on neuroimmunology and neuroinflammation’s relation to neurodegenerative diseases in the challenge to develop clinically effective therapeutics. \n \nThe 2nd Neuroimmunology Drug Development Summit’s agenda has specifically designed alongside neuroimmunology experts from the likes of Denali\, AbbVie and Biogen to help these drug developers to overcome their translational challenges and successfully translate their drug candidates into the clinic. \nImmerse yourself in the field’s cutting-edge scientific advances and take this unrivaled opportunity to join over 23 expert industry speakers and over 80 drug developers from the neuroimmunological community for over 7 hours of dedicated networking time and 2 deep-dive workshops. \nTo find out more and view the full speaker line-up\, download the full event guide.
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-2020/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR